RAC 3.03% $1.70 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-63

  1. 2,806 Posts.
    lightbulb Created with Sketch. 3429
    Yes, my bad. The NDA is even further down the line...

    Point is, if the peadiatric AML isn't pursued, there is a greater commercial opportunity elsewhere.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.